1. Introduction {#sec1-molecules-21-00437}
===============

Lipo-alkaloid is a kind of C19-norditerpenoid alkaloid usually found in *Aconitum* species. Structurally, they consist of an aconitane skeleton and one or two fatty acid moieties of 3--25 carbon chains with 1--6 unsaturated degrees \[[@B1-molecules-21-00437]\]. So far, more than 200 lipo-alkaloids have been reported from plants \[[@B1-molecules-21-00437]\], semisynthesis \[[@B2-molecules-21-00437]\] and biotransformations \[[@B3-molecules-21-00437],[@B4-molecules-21-00437],[@B5-molecules-21-00437]\]. Because naturally-occurring lipo-alkaloids are so close structurally, it is very difficult to purify them from the mixture. Their characterization is mainly conducted by high sensitive mass spectrometry (MS) or liquid chromatography-mass spectrometry (LC-MS) techniques, such as ion trap-MS \[[@B6-molecules-21-00437]\], MALDI-TOF-MS \[[@B7-molecules-21-00437]\], ESI-Fourier Transform Ion Cyclotron Resonance FTICR-MS \[[@B8-molecules-21-00437]\], LC-ESI-Ion TrapIT-MS \[[@B8-molecules-21-00437],[@B9-molecules-21-00437],[@B10-molecules-21-00437]\], and LC-Linear Ion TrapLTQ-Orbitrap-MS \[[@B11-molecules-21-00437]\]. To our knowledge, only one pure lipo-alkaloid, 8-*O*-azeloyl-14-benzoylaconine, was isolated and elucidated by NMR from plants \[[@B12-molecules-21-00437]\]. In this research, the separation of naturally-occurring lipo-alkaloids was optimized using column chromatography (CC), and six pure lipo-alkaloids (**A1**--**A6**) were obtained from a natural source for the first time. At the same time, a mixture of oxygenated fatty acid-containing lipo-alkaloids (**A7**) was also obtained, and the structures were determined by MS/MS analysis after alkaline hydrolysis. Furthermore, a compound database of lipo-alkaloids was established based on the basic skeletons and fatty acids groups, and by the combination of the compound database, UHPLC-Q-TOF-MS and MS/MS analysis, 148 lipo-alkaloids, including 93 potential new ones, were identified from *A. carmichaelii*.

2. Results and Discussion {#sec2-molecules-21-00437}
=========================

2.1. Isolation and Structural Elucidation of Lipo-Alkaloids ***A1**--**A7*** {#sec2dot1-molecules-21-00437}
----------------------------------------------------------------------------

Structurally, lipo-alkaloids usually contain one or two long fatty acid moieties; therefore, they have low polarity and can be extracted by *n*-hexane. After column chromatography separation on silica gel and ODS, a lipo-alkaloids-rich fraction was obtained. Compared to water and methanol as mobile phases, 0.01% diethylamine in water and methanol gave better separation of lipo-alkaloids on a preparative HPLC C18 column ([Figure 1](#molecules-21-00437-f001){ref-type="fig"}A). Seven compounds (**A1**--**A7**) were determined to be lipo-alkaloids by UHPLC-Q-TOF-MS and NMR techniques.

The molecular formula of Compound **A1** was determined as C~49~H~73~NO~11~ based on the quasi-molecular ion at *m*/*z* 852.5254. The base peak at *m*/*z* 572.2863 in the MS/MS spectrum is produced from the neutral loss of C~18~H~32~O~2~ ([Figure 1](#molecules-21-00437-f001){ref-type="fig"}B), indicating the presence of long chain fatty acid moiety. Other fragmentation ions at *m*/*z* 540.2600, 522.2493, 512.2649, 508.2335, 490.2226, 480.2385 and 390.2271 were related to the neutral losses of MeOH, H~2~O, CO and BzOH ([Table 1](#molecules-21-00437-t001){ref-type="table"}), while the fragmentation ion at *m*/*z* 105.0340 was assigned to the benzoyl group. Therefore, the basic skeleton of **A1** should be 14-benzoylmesaconitine (BMA) \[[@B13-molecules-21-00437]\], and this was supported by its ^1^H- and ^13^C-NMR spectra ([Table S1](#app1-molecules-21-00437){ref-type="app"}). ^1^H-NMR also displayed the unconjugated vinylic protons at δ 5.376 (4H, m, H-9″, 10″, 12″, 13″), bis-allylic protons at δ 2.802 (2H, m, H-11″), allylic protons at δ 2.045 (4H, m, H-8″, 14″), acylated methylene at δ 1.450 (1H, m, H-2″a) and 1.816 (1H, m, H-2″b), methylene at δ 1.380 (8H, m, H-7″, 15″, 16″, 17″), 1.177 (2H, m, H-6″), 1.026 (2H, m, H-5″), 1.179 (1H, m, H-3″a), 1.025 (1H, m, H-3″b) and 0.885 (2H, m, H-4″) and a methyl group at δ 0.915 (3H, t, H-18″); thus, the fatty acid moiety was determined to be the linoleoyl group. Comparing to the ^1^H-NMR spectra of free fatty acids, significant up-field shifting was observed for H-2″, H-3″ and H-4″; moreover, the signals of two protons of the methylene at positions 2″ and 3″ were un-equivalent, which should be induced by the 14-benzoyl group. Finally, Compound **A1** was determined to be 8-*O*-linoleoyl-14-benzoylmesaconine.

The molecular formulae of Compounds **A3** and **A4** were C~47~H~73~NO~11~ and C~49~H~75~NO~11~, which were two carbons less and two hydrogens more than that of Compound **A1**. The same MS/MS spectra ([Table S2](#app1-molecules-21-00437){ref-type="app"}) as **A1** indicated that **A3** and **A4** should be BMA derivatives. Meanwhile, the neutral losses of C~16~H~32~O~2~ and C~18~H~34~O~2~ in MS/MS spectra and ^1^H-NMR data ([Table S1](#app1-molecules-21-00437){ref-type="app"}) suggested that the side chains for **A3** and **A4** were palmitic acid and oleic acid, respectively. Therefore, their structures were determined to be 8-*O*-palmitoyl-14-benzoylmesaconine (**A3**) and 8-*O*-oleoyl-14-benzoylmesaconine (**A4**).

The molecular formula of Peak **A2** was determined as C~50~H~75~NO~11~ from the high resolution MS, which was one carbon and two hydrogens more than that of **A1**. The pattern of fragmentation ions of **A2** was very similar to that of **A1** with most of the peaks moved 14 Da (CH~2~) to the right side ([Figure 1](#molecules-21-00437-f001){ref-type="fig"}B and [Table 1](#molecules-21-00437-t001){ref-type="table"}). The ^1^H-NMR spectrum of **A2** showed the presence of *N*CH~2~CH~3~ ([Table S1](#app1-molecules-21-00437){ref-type="app"}); therefore, the basic skeleton should be 14-benzoylaconine (BA), and it was determined to be 8-*O*-linoleoyl-14-benzoylaconine. With a similar comparison, Compounds **A5** (C~48~H~75~NO~11~) and **A6** (C~50~H~77~NO~11~) were determined to be 8-*O*-palmitoyl-14-benzoylaconine and 8-*O*-oleoyl-14-benzoylaconine, respectively, based on their MS/MS and ^1^H-NMR spectra.

Peak **A7** was obtained as a single peak in the UHPLC-MS chromatogram and with a quasi-molecular ion at *m*/*z* 868.5228, which is in agreement with the molecular formula of C~49~H~73~NO~12~ that is one oxygen more than that of **A1**. The MS/MS spectrum showed that **A7** was a BMA derivative with C~18~H~32~O~3~ as the side chain ([Figure 1](#molecules-21-00437-f001){ref-type="fig"}C). However, the ^1^H-NMR spectrum of **A7** was unexpectedly complicated. Except for BMA signals, the unconjugated vinyl protons at δ 5.371 (4H, m), bis-allylic methylene at δ 2.790, allylic methylene at *δ* 2.051 and methylene at around *δ* 1.3, there were three proton signals at δ 4.413, 4.189 and 4.127 with unproportioned integrations to other signals. Therefore, **A7** might be a mixture containing different side chains. After alkaline hydrolysis of **A7**, the released fatty acids were analyzed by UHPLC-MS and MS/MS, and the results are shown in [Figure 2](#molecules-21-00437-f002){ref-type="fig"}. At least four peaks were detected at 4.4, 5.1, 5.5 and 6.4 min with the same *m*/*z* at 295.23 (C~18~H~32~O~3~), but their MS/MS spectra were significantly different ([Figure 2](#molecules-21-00437-f002){ref-type="fig"}B). In the MS/MS spectrum of the peak at 5.1 min, the fragmentation ions at *m*/*z* 277.2191 (\[M − H − H~2~O\]^−^) and 195.1407 (\[M − H − C~6~H~12~O\]^−^) indicate the presence of a hydroxyl group at C-13 \[[@B14-molecules-21-00437]\] and the unconjugated vinyl bonds should be between C-2 and C-12, *i.e.*, 13-hydroxyoctadecadienoic acid. The fragmentation ions in the MS/MS spectrum for the third peak at 5.5 min were related to the neutral losses of H~2~O, C~8~H~16~ and CO, just like the MS/MS spectrum of 10-hydroxyoctadecadienoic acid \[[@B15-molecules-21-00437]\]. The fourth peak was identified as 9-hydroxyoctadecadienoic acid based on the ions of \[M − H − H~2~O\]^−^ and \[M − H − C~9~H~16~\]^−^ \[[@B14-molecules-21-00437]\]. For the first peak, the fragmentation ions from the neutral losses of H~2~O and C~5~H~12~O were observed. The cleavage of hydroxyl group usually gives an unsaturated carbonyl group, which is different from the neutral loss of C~5~H~12~O, so the fatty acid at 4.4 min needs further investigation. Finally, Peak **A7** was determined as the mixture of the oxygenated fatty acids-containing BMA derivative by the combination of ^1^H-NMR and MS/MS analysis after alkaline hydrolysis.

As a result, six pure lipo-alkaloids were obtained by optimized column chromatography and characterized as 8-*O*-linoleoyl-14-benzoylmesaconine (**A1**), 8-*O*-linoleoyl-14-benzoylaconine (**A2**), 8-*O*-palmitoyl-14-benzoylmesaconine (**A3**), 8-*O*-oleoyl-14-benzoylmesaconine (**A4**), 8-*O*-palmitoyl-14-benzoylaconine (**A5**) and 8-*O*-oleoyl-14-benzoylaconine (**A6**), respectively. Although these compounds were identified by LC-MS and/or semi-synthetic methods before, this is the first time that they have been purified from nature. Besides, oxygenated fatty acid-containing lipo-alkaloids were firstly obtained, and they shared the same aconitane skeleton of 14-benzoylmesaconine, while their side chains were determined to be 9-hydroxy-octadecadienoic acid, 13-hydroxy-octadecadienoic acid and 10-hydroxy-octadecadienoic acid, respectively. Their structures are shown in [Figure 3](#molecules-21-00437-f003){ref-type="fig"}.

2.2. Establishment of Lipo-Alkaloids Database {#sec2dot2-molecules-21-00437}
---------------------------------------------

In the structures of the previously-reported naturally-occurring lipo-alkaloids \[[@B1-molecules-21-00437],[@B11-molecules-21-00437]\], there were 13 basic aconitine skeletons and 51 fatty acid chains. Oxygenated fatty acids are widely present in plants; thus, it is possible that these fatty acids connect with aconitane skeletons to form the lipo-alkaloids, as reported above. All possible lipo-alkaloids can be hypothesized by the following formula:

Herein, MF~lipo-alkaloid~ and MF~basic\ skeleton~ are the molecular formulae of potential lipo-alkaloids and the 13 reported aconitane skeletons, while MF~fatty\ acid~ is the molecular formula of possible fatty acids, which have 3--25 carbons and 2--6 oxygen atoms with the unsaturated degrees from 1--7. Then, the names and molecular formulae of the hypothesized lipo-alkaloids were input into an Agilent MassHunter database file to establish an in-house lipo-alkaloids database with a total of 484 molecular formulae.

2.3. Determination of Lipo-Alkaloids by Combination of Database, UHPLC-Q-TOF-MS and MS/MS Analysis {#sec2dot3-molecules-21-00437}
--------------------------------------------------------------------------------------------------

Based on information from the lipo-alkaloids database, UHPLC-Q-TOF-MS and MS/MS analysis, 148 lipo-alkaloids, including 93 potential new ones, were determined ([Table 2](#molecules-21-00437-t002){ref-type="table"} and [Figure 4](#molecules-21-00437-f004){ref-type="fig"}). Among them, 21 molecular formulae were found to have at least two isomers with different MS/MS spectra and/or retention times, e.g., Compounds **71** and **102**, **79** and **122**, **62**, **72** and **109**. Compounds **71** and **102** had the same molecular formula of C~49~H~73~NO~11~. Compound **102** has the same retention time, MS and MS/MS spectra as Compound **A1**, 8-*O*-linoleoyl-14-benzoylmesaconine. The MS/MS base peak of **71** was at *m*/*z* 556.2919, which was one oxygen less than that of **A1**; other fragmentation ions were also one oxygen less than the corresponding ions in **A1**, and no ion related to neutral loss of CO was observed ([Table 1](#molecules-21-00437-t001){ref-type="table"}). Therefore, the basic skeleton of **71** was identified as 14-benzyolhypaconine (BHA). The fatty acid in **71** was determined to have a formula of C~18~H~32~O~3~, corresponding to a hydroxyoctadecadienoic acid as in Compound **A7**. Similarly, Compounds **79** and **122** have the same molecular formula of C~49~H~75~NO~11~ with two more hydrogens than **71** and **A1**. Compound **122** was unambiguously determined as 8-*O*-oleoyl-14-benzoylmesaconine based on the same retention time, MS and MS/MS spectra as **A4**. The MS/MS spectrum of **79** suggested a basic skeleton of BHA, so the fatty acid should have two hydrogens more than that in **71**, *i.e.*, hydroxyoctadecenoic acid (C~18~H~34~O~3~) in **79**. Compounds **61**, **72** and **109** had one oxygen more than **79** and **A4**, and the fragmentation patterns of **61** and **72** were almost the same as those of **79** and **A4**; thus, the additional oxygen should substitute on the fatty acid side chains, which are C~18~H~34~O~4~ and C~18~H~34~O~3~, respectively. The MS/MS base peak ion of Compound **109** showed one oxygen more than that of **72**, and other fragmentation ions were also 16 Da more than that of Compound **72**; therefore, the basic skeleton should be 10-OH-BMA. Therefore, Compound **109** was identified as 8-*O*-oleoyl-10-hydroxy-14-benzoylmesaconine. Similarly, by comprehensive analysis of the MS/MS spectra, 22 other fatty acid chains, e.g., C~18~H~30~O~3~, C~18~H~32~O~4~, C~18~H~36~O~3~ and C~23~H~46~O~2~, were also determined, as shown in [Table 3](#molecules-21-00437-t003){ref-type="table"}.

In addition to 13 known aconitane skeletons included in the database, four new aconitane skeletons were found in the identified lipo-alkaloids for the first time ([Figure 5](#molecules-21-00437-f005){ref-type="fig"}). The elucidation of new skeletons is discussed below, while the MS/MS characterization of known skeletons is shown in [Figure 6](#molecules-21-00437-f006){ref-type="fig"} and [Table 1](#molecules-21-00437-t001){ref-type="table"}.

Compounds **85**, **103**, **116** and **117** shared the same fragmentation patterns, in which *m*/*z* 540.30 (\[M + H − FA\]^+^), 508.27 (\[M + H − FA − CH~3~OH\]^+^), 480.28 (\[M + H − FA − CH~3~OH − CO\]^+^), 476.24 (\[M + H − FA − 2CH~3~OH\]^+^), 448.24 (\[M + H − FA − 2CH~3~OH − CO\]^+^), 354.21 (\[M + H − FA − 2CH~3~OH − benzoic acid\]^+^) and 105.03 (\[C~6~H~5~CO\]^+^) were the major ions ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}E). Except for the ion at *m*/*z* 354.21, all other ions contained one OCH~2~ group less than that of 3-deoxy-14-benzoylaconine (3-DBA) derivatives ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}C); therefore the basic skeleton was determined to be demethoxy-3-deoxy-14-benzoylaconine (3-DMDBA). The ion at *m*/*z* 354.21 was derived from the loss of two methanols rather than three methanols, which in turn further confirmed that the basic skeleton had one methoxyl group less than 3-DBA with 1-OCH~3~ or 6-OCH~3~ missing ([Scheme S4](#app1-molecules-21-00437){ref-type="app"}).

The isomers of Compounds **103**, **117** and **116** were observed at the retention times of 24.5 min (**97**), 26.0 (**115**) and 26.1 min (**119**), respectively. They had similar MS/MS fragmentation ions, which were significantly different from Compounds **103**, **117** and **116**. The ions of \[M + H − FA\]^+^, \[M + H − FA − CH~3~OH\]^+^, \[M + H − FA − CH~3~OH − CO\]^+^, \[M + H − FA − 2CH~3~OH\]^+^, \[M + H − FA − 2CH~3~OH − CO\]^+^ and \[C~6~H~5~CO\]^+^ were also observed, but the relative intensities of \[M + H − FA\]^+^ and \[M + H − FA − CH~3~OH − CO\]^+^ were higher than others ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}F). More importantly, there was no evidence of the losses of FA + 2CH~3~OH + benzoic acid, so that the basic skeleton should be demethoxy-13-deoxy-14-benzoylaconine (13-DMDBA).

Compounds **51**, **95** and **110** had the molecular formulae of C~46~H~71~NO~9~, C~48~H~71~NO~9~ and C~48~H~73~NO~9~, and their fragmentation ions were mainly generated from the neutral losses of FA, methanol and benzoic acid showing at *m*/*z* 526.28, 494.25, 462.23 and 340.19 ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}G and [Scheme S3](#app1-molecules-21-00437){ref-type="app"}). The fragmentation patterns were very similar to those of 3-DMDBA derivatives ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}E), but with one CH~2~ less. The ions corresponding to the loss of two molecules of methanol at *m*/*z* 462.23 (\[M + H − FA − 2CH~3~OH\]^+^) and 340.19 (\[M + H − FA − 2CH~3~OH − benzoic acid\]^+^) indicated that the differences were the substitution groups on the *N* atom, and it should be *N*-CH~3~ rather than *N*-C~2~H~5~ in these three compounds, *i.e.*, the basic skeleton should be demethoxy-14-benzoylhypaconine (DMBHA).

Compounds **105**, **120**, **131** and **137** shared the same fragment ions at *m*/*z* 524.30, 492.27, 464.28, 460.25 and 432.25 ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}H). The fragmentation patterns were very similar to those compounds with 3-DMDBA as the basic skeleton ([Figure 6](#molecules-21-00437-f006){ref-type="fig"}E), but with one oxygen less. Because there was no ion produced from the loss of FA + methanol + benzoic acid, the absence of 13-OH was indicated; therefore, the basic skeleton should be demethoxy-3,13-dideoxy-14-benzoylaconine (DMDDBA).

Based on the finding of oxygenated fatty acids as the side chains of lipo-alkaloids, the possible lipo-alkaloids were predicted and included in an in-house database. By the combination of the database, UHPLC-MS and MS/MS analysis, not only more oxygenated fatty acid-containing lipo-alkaloids were determined, but also four aconitane skeletons not reported in lipo-alkaloids before were detected. Finally, 148 lipo-alkaloids, including 93 potential new ones, were identified ([Table 2](#molecules-21-00437-t002){ref-type="table"}). Although most of previous reports showed that the contents of lipo-alkaloids usually increased after processing, no significant difference was detected when using heat reflux extraction or ultrasonic extraction in our preliminary research (data not shown).

2.4. MS/MS Characterizations of Aconitane Skeletons in Lipo-Alkaloids {#sec2dot4-molecules-21-00437}
---------------------------------------------------------------------

In this study, we reported 13 aconitane skeletons (including four new ones) in the lipo-alkaloids with their main fragmentation ions from the neutral losses of MeOH, H~2~O, CO and BzOH ([Figure 6](#molecules-21-00437-f006){ref-type="fig"} and [Table 1](#molecules-21-00437-t001){ref-type="table"}). Based on structures and MS/MS spectra, the relationship between the substitutions and the fragmentation ions can be summarized as follows. (1) The ions produced from the neutral loss of MeOH have higher abundance, and the numbers of methoxy group substituted on aconitane skeleton usually are determined from the corresponding ions. For instance, ions with the loss of three molecules of methanol were detected for the aconitine skeletons with tetramethoxy substitution, while ions with neutral loss of two molecules of methanol were observed for the trimethoxy-substituted skeletons. Due to the higher bond energy between C~18~ and the methoxy group \[[@B22-molecules-21-00437]\], it is difficult to detect the fragment ions from the loss of C~18~-OMe; (2) The ion corresponding to the neutral loss of BzOH should be a diagnostic ion of 13-OH-14-OBz. The ion of \[M + H − FA − 3CH~3~OH − BzOH\]^+^ was observed for the lipo-alkaloids with the basic skeletons of 3-Ac-BMA, 10-OH-BA, 10-OH-MA, BA, BMA, DBA and BHA, and the ion of \[M + H-FA-2CH~3~OH-BzOH\]^+^ was detected from the derivatives of 3-DMDBA and DMBHA, while no evident ion was found in MS/MS spectra of the 3,13-DDBA, 13-DMDBA and 3,13-DMDDBA derivatives ([Table 1](#molecules-21-00437-t001){ref-type="table"}). Moreover, the aforementioned ion could also be used to determine the numbers of methoxy groups substituted on the aconitane skeletons; (3) The ions of the loss of CO indicates the presence of the 15-OH-16-OMe group \[[@B11-molecules-21-00437]\], e.g., \[M + H − FA − 2CH~3~OH − CO\]^+^ was observed in all identified lipo-alkaloids. (4) The loss of H~2~O usually indicates the substitution of a hydroxyl group at C-3. There is no such ion observed in DBA, BHA, 3, 13-DDBA, 3-DMDBA, DMBHA and 3, 13-DMDDBA.

2.5. Fatty Acid Side Chains in Lipo-Alkaloids {#sec2dot5-molecules-21-00437}
---------------------------------------------

Besides common long chain fatty acids, medium and long chain oxidized fatty acids were detected as the side chains of lipo-alkaloids in plants for the first time, e.g., C~9~H~16~O~3~, C~18~H~30~O~3~, C~18~H~32~O~3~, C~18~H~32~O~4~, C~18~H~34~O~3~, C~18~H~34~O~4~, C~18~H~34~O~5~, and so on ([Table 3](#molecules-21-00437-t003){ref-type="table"}). These oxygenated fatty acids might occur as hydroxyl-, oxo-, epoxy-, hydroperoxy-type or diacid \[[@B23-molecules-21-00437]\]. However, due to the limitation of LC-MS data, it is difficult to determine in which form they exist in the lipo-alkaloids. In this study, three oxygenated fatty acids in a lipo-alkaloids mixture were determined by ^1^H-NMR, alkaline hydrolysis and MS/MS analysis, but other oxygenated fatty acid groups could not be determined due to the limited amount of sample available. Considering the polarity and occurrence of fatty acids in nature, the most possible structures were proposed in [Table 2](#molecules-21-00437-t002){ref-type="table"} by searching the lipid maps \[[@B24-molecules-21-00437]\] and comparing retention times of the lipo-alkaloids to common fatty acid side chains.

Plant oxylipins are involved in the stress responses, and some of them have anti-microbial and anti-insecticidal activities \[[@B25-molecules-21-00437]\]. Some oxylipins, e.g., 2-hydroxyoleic acid (C~18~H~34~O~3~), were found to have anti-cancer activity \[[@B26-molecules-21-00437]\], while some oxylipins have anti-inflammatory activity \[[@B27-molecules-21-00437]\]. When these oxidized fatty acids connect to aconitane alkaloids to form the lipo-alkaloids, the bioactivity and toxicity of aconitane alkaloids might change. Thus, the occurrence, bioactivity and toxicity of these oxygenated fatty acid-containing lipo-alkaloids are worth further investigations.

3. Materials and Methods {#sec3-molecules-21-00437}
========================

3.1. Chemicals and Reagents {#sec3dot1-molecules-21-00437}
---------------------------

AR-grade *n*-hexane, dichloromethane, *n*-butanol, methanol and HPLC-grade methanol were obtained from Anaqua Chemicals Supply (Houston, TX, USA). MS-grade acetonitrile, methanol and water were purchased from J.T. Baker (Danville, PA, USA), and MS-grade formic acid was provided by Sigma-Aldrich Laboratories, Inc. (St. Louis, MO, USA). AR-grade potassium hydroxide, hydrochloric acid (37%), and diethylamine were purchased from Merck and Advanced Technology & Industrial CO. Ltd. (Hong Kong, China), respectively. Silica gel (75--150 mesh) and ODS (35--70 µm) were provided by Grace (Columbia, MD, USA).

3.2. Plant Materials {#sec3dot2-molecules-21-00437}
--------------------

The roots of *Aconitum carmichaelii* Debx. (ChW-02) were obtained from Hehuachi Medicinal Materials Market in Chengdu, Sichuan Province of China, and authenticated by Ying Liu, Chengdu University. A voucher specimen was deposited in Macau University of Science and Technology.

3.3. Separation of Lipo-Alkaloids {#sec3dot3-molecules-21-00437}
---------------------------------

The air-dried roots of *A. carmichaelii* (7.2 kg) were powdered and soaked in methanol (12 L) at room temperature for one week and then extracted with methanol at reflux 3 times (3 × 12 L, 1 h for each extraction). The combined methanol extracts were evaporated under vacuum to give 356 g of residue, which was suspended in distilled water (3 L) followed by the participation with *n*-hexane (3 × 3 L), ethyl acetate (3 × 3 L) and *n*-butanol (3 × 3 L), successively. The *n*-hexane extract (32 g) was subjected to silica gel CC (6 × 60 cm) using CH~2~Cl~2~/CH~3~OH as the eluate to provide four fractions (A--D). Fraction D (5 g) was further subjected to ODS CC (4.5 × 50 cm) using water-containing methanol (0%--100%) as the eluate to produce five subfractions (D1--5). Subfraction D4 (1 g) was divided into 10 parts by another ODS CC with an increasing gradient of water-containing methanol (40%--100%). Preparative HPLC separation of the eighth part (D4--8, 134 mg) on an ODS column (10 × 250 mm, 5 µm) produced 7 compounds, 8 mg **A1**, 6 mg **A2**, 3 mg **A3**, 9 mg **A4**, 7 mg **A5**, 3 mg **A6** and 4 mg **A7**. The mobile phases were 0.01% diethylamine-containing water (A) and methanol (B) with the following gradient: 0--40 min, 70%--95 B%; 40--120 min, 95% B. The flow rate was 2 mL/min, and the detection wavelength was set at 230 nm. The structures were characterized by NMR and mass spectrometry.

3.4. Alkaline Hydrolysis of Peak ***A7*** {#sec3dot4-molecules-21-00437}
-----------------------------------------

One milligram of A7 was dissolved in 400 µL of KOH-saturated methanol solution and then heated to 75 °C for 15 min and 60 min. The reaction solution was neutralized with 800 µL of 5 M HCl-MeOH and participated with ethyl acetate, respectively. The ethyl acetate layer was analyzed by UHPLC-Q-TOF-MS.

3.5. Preparation of Methanol Extracts of Herbal Sample {#sec3dot5-molecules-21-00437}
------------------------------------------------------

One gram of powdered herbal sample was extracted with 6 mL methanol for 60 min with the aid of an ultrasonicator and then centrifuged at 13,000 rpm for 10 min. The supernatant was collected and diluted 10-times, then followed by the acquisition of UHPLC-Q-TOF-MS data.

3.6. UHPLC-Q-TOF-MS Analysis {#sec3dot6-molecules-21-00437}
----------------------------

Agilent 1290 UHPLC system (UHPLC, Agilent Technologies, Santa Clara, CA, USA) consisting of an autosampler, thermostated column compartment and binary pump and equipped with an Agilent Eclipse C18 column (2.1 × 100 mm, 1.8 μm, Agilent Technologies) was applied for the separation of components. The mobile phases were 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). Method 1 was applied for the determination of lipo-alkaloids, and the mobile phase gradient was set as follows, 0--0.5 min, 20% B; 0.5--30 min, 20%--98% B; 30--33 min 98% B; 33--33.1 min, 98%--20% B, and then maintained for 2 min. Method 2 was used for the analysis of fatty acids, and the gradient was 0--11 min, 25% B, 11--11.1 min, 25%--95% B, and then maintained for 2 min. The flow rate was 0.3 mL/min, and the injection volume was 2 µL. The mass spectrometry was conducted on a 6550 UHD Accurate-Mass Q-TOF/MS system (Agilent Technologies) with a dual Agilent Jet Stream electrospray ion source (dual AJS ESI). The mass parameters were optimized using the standards of aconitine, mesaconitine and hypaconitine and set as follows: dry gas temperature and flow were 250 °C and 15 L/min; sheath gas temperature and flow were 300 °C and 11 L/min; nebulizer at 20 psi; the capillary and nozzle voltages were 4000 and 500 V, respectively. The fragmentor was 380 V, and the collision cell energies were set at 50 eV for lipo-alkaloids in positive mode and 30 eV for fatty acids in negative mode, respectively.

3.7. Establishment of the Lipo-Alkaloids Database {#sec3dot7-molecules-21-00437}
-------------------------------------------------

Based on the possible fatty acid chains and known aconitane skeletons reported in *Aconitum* plants, the possible lipo-alkaloids were hypothesized and input into Agilent MassHunter database file ("Compound Formula Database") to establish an in-house lipo-alkaloids database. Then, the potential lipo-alkaloids in *A. carmichaelii* were extracted using the function of "Find Compounds by Formula (FBF)" and determined by MS/MS analysis.

4. Conclusions {#sec4-molecules-21-00437}
==============

In this study, the separation method of lipo-alkaloids was optimized, and using this method, oxygenated fatty acids-containing lipo-alkaloids were obtained for the first time. A lipo-alkaloids database was established based on the known basic aconitane skeletons and possible fatty acid side chains. By using the database, potential lipo-alkaloids were first extracted from UHPLC-Q-TOF-MS, and then, the structures were determined from the comprehensive analysis and deduction of MS/MS spectra, resulting in successful identification of 148 lipo-alkaloids. Among them, 38 compounds contain medium or long chain oxidized fatty acids as side chains that were not reported previously. The combination of database and LC-MS dramatically speeds up the finding of potential new compounds and is confirmed to be a powerful tool in the study of natural product chemistry. The new finding of oxygenated fatty acids as side chains of lipo-alkaloids provides a kind of possible structures, which accounts for the bioactivities of *A. carmichaelii*, a widely-used traditional medicine.

This work was supported by the Macao Science and Technology Development Fund (086/2013/A3).

**Sample Availability:** Not available.

###### 

Click here for additional data file.

Supplementary materials can be accessed at: <http://www.mdpi.com/1420-3049/21/4/437/s1>.

Liang Liu and Na Li conceived of and designed the experiments. Ying Liang, Jian-Lin Wu, Guanyu Yan and Na Li performed the experiments and analyzed the data. Ying Liu collected and authenticated the herbs. Elaine Lai-Han Leung, Hua Zhou, Zhongqiu Liu and Na Li wrote the paper. All authors read and approved the final manuscript.

The authors declare no conflict of interest.

The following abbreviations are used in this manuscript: UHPLC-Q-TOF-MSultra-high performance liquid chromatography-quadrupole-time of flight-mass spectrometryBA14-benzoylaconineBMA14-benzoylmesaconineBHA14-benzoylhypaconine10-OH-BA10-hydroxy-14-benzoylaconine3-DBA3-deoxy-14-benzoylaconine15-DBA15-deoxy-14-benzoylaconine3,13-DDBA3,13-dideoxy-14-benzoylaconine10-OH-BMA10-hydroxy-14-benzoylmesaconine15-DBHA15-deoxy-14-benzoylhypaconine3-Ac-10-OH-BA3-acetyl-10-hydroxy-14-benzoylaconine3-Ac-10-OH-BMA3-acetyl-10-hydroxy-14-benzoylmesaconine3-Ac-BA3-acetyl-14-benzoylaconine3-Ac-BMA3-acetyl-14-benzoylmesaconine3-DMDBAdemethoxy-3-deoxy-14-benzoylaconine13-DMDBAdemethoxy-13-deoxy-14-benzoylaconineDMDDBAdemethoxy-3,13-dideoxy-14-benzoylaconineDMBHAdemethoxy-14-benzoylhypaconine

![Preparative HPLC chromatogram of Fraction **D4-1-8** (**A**); MS/MS and expanded MS/MS spectra of Compounds **A1**, **A2** and **71** (**B**); MS and MS/MS spectra of Compound **A7** (**C**).](molecules-21-00437-g001){#molecules-21-00437-f001}

![LC-MS chromatogram (**A**) and MS/MS spectra (**B**) of fatty acids released by alkaline hydrolysis.](molecules-21-00437-g002){#molecules-21-00437-f002}

![Structures of isolated lipo-alkaloids (**A1**--**A7**).](molecules-21-00437-g003){#molecules-21-00437-f003}

![UHPLC-MS chromatogram of the identified lipo-alkaloids in *A. carmichaelii*.](molecules-21-00437-g004){#molecules-21-00437-f004}

![Structures of aconitane skeletons of lipo-alkaloids. \* Indicates the skeleton was detected for the first time.](molecules-21-00437-g005){#molecules-21-00437-f005}

![MS/MS spectra of lipo-alkaloids with the basic skeletons of: (**A and A1**) 10-OH-BA; (**B and B1**) 10-OH-BMA; (**C**) 3-DBA; (**D**) 3,13-DDBA; (**E**) 3-DMDBA; (**F**) 13-DMDBA; (**G**) DMBHA; (**H**) DMDDBA.](molecules-21-00437-g006){#molecules-21-00437-f006}

molecules-21-00437-t001_Table 1

###### 

MS/MS characteristic fragmentation ions of aconitane skeletons in lipo-alkaloids ^a^.

  Basic Skeleton   \[M + H − FA\]^+^   \[M + H − FA − CH~3~OH\]^+^   \[M + H − FA − CH~3~OH − H~2~O\]^+^   \[M + H − FA − CH~3~OH − CO\]^+^   \[M + H − FA − 2CH~3~OH\]^+^   \[M + H − FA − 2CH~3~OH − H~2~O\]^+^   \[M + H − FA − 2CH~3~OH − CO\]^+^   \[M + H − FA − 3CH~3~OH\]^+^   \[M + H − FA − 2CH~3~OH − BzOH\]^+^   \[M + H − FA − 3CH~3~OH − BzOH\]^+^   \[M + H − FA − 3CH~3~OH − BzOH − AcOH\]^+^
  ---------------- ------------------- ----------------------------- ------------------------------------- ---------------------------------- ------------------------------ -------------------------------------- ----------------------------------- ------------------------------ ------------------------------------- ------------------------------------- --------------------------------------------
  3-Ac-BMA         614.2965            582.2703                      \-                                    554.2754                           550.2441                       \-                                     522.2492                            \-                             \-                                    396.1811                              336.1600
  10-OH-BA         602.2965            570.2703                      552.2597                              542.2754                           538.2441                       520.2335                               510.2492                            506.2179                       weak                                  384.1811                              \-
  10-OH-BMA        588.2809            556.2547                      538.2441                              528.2597                           524.2284                       506.2179                               496.2335                            492.2022                       weak                                  370.1654                              \-
  BA               586.3016            554.2754                      536.2648                              526.2805                           522.2492                       504.2386                               494.2543                            490.2230                       weak                                  368.1862                              \-
  BMA              572.2860            540.2597                      522.2492                              512.2648                           508.2335                       490.2230                               480.2386                            476.2073                       weak                                  354.1705                              \-
  DBA              570.3067            538.2805                      \-                                    510.2856                           506.2543                       \-                                     478.2593                            \-                             weak                                  352.1913                              \-
  BHA              556.2910            524.2648                      \-                                    496.2704                           492.2386                       \-                                     464.2437                            460.2124                       weak                                  338.1756                              \-
  3,13-DDBA        554.3118            522.2856                      \-                                    494.2906                           490.2593                       \-                                     462.2644                            458.2331                       \-                                    \-                                    \-
  3-DMDBA \*       540.2961            508.2699                      \-                                    480.2750                           476.2437                       \-                                     448.2448                            \-                             354.2069                              \-                                    \-
  13-DMDBA \*      540.2961            508.2699                      490.2593                              480.2750                           476.2437                       458.2331                               448.2448                            \-                             \-                                    \-                                    \-
  DMBHA \*         526.2805            494.2543                      \-                                    \-                                 462.2280                       \-                                     434.2331                            \-                             340.1913                              \-                                    \-
  3,13-DMDDBA \*   524.3014            492.2750                      \-                                    464.2801                           460.2488                       \-                                     432.2539                            \-                             \-                                    \-                                    \-

^a^ The *m*/*z* of fragmentation ions is shown as calculated values. \* New skeleton found in lipo-alkaloid. FA: fatty acid.

molecules-21-00437-t002_Table 2

###### 

Lipo-alkaloids identified from *A. carmichaelii*.

  No.   Rt (min)   Calcd. \[M + H\]^+^   \[M + H\]^+^   Alkaloids             Ref.                           No.   Rt (min)   Calcd. \[M + H\]^+^   \[M + H\]^+^   Alkaloids                Ref.
  ----- ---------- --------------------- -------------- --------------------- ------------------------------ ----- ---------- --------------------- -------------- ------------------------ -------------------------------
  1     3.4        692.3277              692.3285       8-dhbtn-BMA \*                                       75    21.8       884.5519              884.5494       8-hode-BA \*             
  2     3.4        762.2968              762.2968       8-act-10-OH-BMA \*                                   76    22.4       866.5049              866.5061       8-linolen-10-OH-BMA      \[[@B16-molecules-21-00437]\]
  3     3.6        902.3805              902.3777       8-gvl-BMA \*                                         77    22.5       880.5206              880.5193       8-linolen-10-OH-BA       \[[@B16-molecules-21-00437]\]
  4     3.8        746.3018              746.3002       8-act-BMA \*                                         78    22.5       824.4943              824.4888       8-pmde-BMA               \[[@B8-molecules-21-00437]\]
  5     4.0        692.3277              692.3258       8-hbtn-10-OH-BMA \*                                  79    22.7       854.5413              854.5409       8-hode-BHA               \[[@B8-molecules-21-00437]\]
  6     4.2        914.3805              914.3784       8-gcf-BMA \*                                         80    22.9       850.5100              850.5105       8-linolen-BMA            \[[@B6-molecules-21-00437]\]
  7     4.5        928.3961              928.3946       8-gfr-BMA \*                                         81    22.9       812.4943              812.4874       8-ptde-BMA               \[[@B6-molecules-21-00437]\]
  8     4.6        730.3069              730.3041       8-act-BHA \*                                         82    23.0       772.4630              772.4618       8-laur-BMA \*            
  9     4.7        734.3382              734.3324       8-adp-10-OH-BMA \*                                   83    23.1       864.5256              864.5252       8-linolen-BA             \[[@B8-molecules-21-00437]\]
  10    4.7        734.3382              734.3324       8-hadp-BMA \*                                        84    23.2       826.5100              826.5052       8-pme-BMA                \[[@B7-molecules-21-00437]\]
  11    4.8        676.3328              676.3321       8-hbtn-BMA \*                                        85    23.3       818.5202              818.5209       8-linolen-3-DMDBA \*     
  12    5.0        760.3175              760.3189       8-act-BA \*                                          86    23.4       848.5307              848.5310       8-linolen-DBA            \[[@B6-molecules-21-00437]\]
  13    5.3        760.3175              760.3176       8-dohpnd-BMA \*                                      87    23.6       868.5206              868.5195       8-lino-10-OH-BMA         \[[@B17-molecules-21-00437]\]
  14    5.6        672.3015              672.3020       8-fmr-BHA \*                                         88    23.8       838.5100              838.5105       8-hpdde-BMA \*           
  15    5.8        660.3384              660.3380       8-hbtn-BHA \*                                        89    23.8       840.5256              840.5184       8-pme-BA                 \[[@B18-molecules-21-00437]\]
  16    5.8        744.3226              744.3244       8-act-DBA \*                                         90    23.9       868.5569              868.5559       8-hode-DBA \*            
  17    5.9        942.4118              942.4084       8-gfr-BA \*                                          91    23.9       882.5362              882.5317       8-lino-10-OH-BA          \[[@B8-molecules-21-00437]\]
  18    6.2        704.3277              704.3249       8-scn-BA              \[[@B2-molecules-21-00437]\]   92    24.1       822.5151              822.5140       8-hpdde-BHA \*           
  19    6.3        674.3173              674.3172       8-scn-BHA \*                                         93    24.2       834.5151              834.5136       8-linolen-BHA            \[[@B6-molecules-21-00437]\]
  20    6.6        732.3590              732.3601       8-adp-BA              \[[@B2-molecules-21-00437]\]   94    24.2       844.5206              844.5218       8-pal-10-OH-BMA          \[[@B6-molecules-21-00437]\]
  21    6.7        702.3484              702.3473       8-adp-BHA \*                                         95    24.3       806.5202              806.5190       8-lino-DMBHA \*          
  22    6.8        674.3535              674.3499       8-hbte-DBA \*                                        96    24.3       784.4994              784.4973       8-myr-BHA                \[[@B19-molecules-21-00437]\]
  23    6.9        686.3171              686.3170       8-fmr-DBA \*                                         97    24.4       820.5358              820.5348       8-lino-13-DMDBA \*       
  24    7.2        688.3691              688.3682       8-hvlr-DBA \*                                        98    24.5       840.5256              840.5249       8-hpde-BMA               \[[@B8-molecules-21-00437]\]
  25    7.6        686.3171              686.3173       8-gtn-BHA \*                                         99    24.6       814.5100              814.5087       8-ptdn-BMA               \[[@B6-molecules-21-00437]\]
  26    7.7        716.3641              716.3633       8-adp-DBA \*                                         100   24.6       796.4994              796.4960       8-ptde-BHA               \[[@B8-molecules-21-00437]\]
  27    8.2        718.3433              718.3443       8-gtr-BA              \[[@B2-molecules-21-00437]\]   101   24.7       854.5413              854.5778       8-hstr-DMA \*            
  28    8.7        658.3222              658.3244       8-bte-BMA \*                                         102   24.8       852.5256              852.5254       8-lino-BMA               \[[@B6-molecules-21-00437]\]
  29    9.8        760.3903              760.3903       8-azl-BMA \*                                         103   24.9       820.5358              820.5359       8-lino-3-DMDBA \*        
  30    10.3       744.4059              774.4051       8-sbc-BMA \*                                         104   25.0       832.5358              832.5355       8-linolen-3,13-DDBA \*   
  31    10.8       644.3429              644.3423       8-btn-BHA \*                                         105   25.0       802.5252              802.5237       8-linolen-DMDDBA \*      
  32    10.8       674.3535              674.3529       8-btn-BA \*                                          106   25.1       836.5307              836.5293       8-lino-BHA               \[[@B6-molecules-21-00437]\]
  33    10.8       674.3535              674.3529       8-vlr-BMA\*                                          107   25.1       810.5151              810.5145       8-pme-BHA                \[[@B8-molecules-21-00437]\]
  34    10.9       744.3954              744.3960       8-hnne-BMA \*                                        108   25.3       866.5413              866.5408       8-lino-BA                \[[@B20-molecules-21-00437]\]
  35    11.4       902.5266              902.5268       8-thode-BMA \*                                       109   25.3       870.5362              870.5372       8-ole-10-OH-BMA          \[[@B6-molecules-21-00437]\]
  36    11.5       758.4110              758.4119       8-azl-DBA \*                                         110   25.5       808.5358              808.5306       8-ole-DMBHA \*           
  37    11.6       758.4110              758.4107       8-hnne-BA \*                                         111   25.5       828.5256              828.5264       8-ptdn-BA                \[[@B6-molecules-21-00437]\]
  38    11.8       688.3691              688.3678       8-vlr-BA              \[[@B4-molecules-21-00437]\]   112   25.7       858.5362              858.5352       8-pal-10-OH-BA           \[[@B6-molecules-21-00437]\]
  39    12.0       658.3586              658.3558       8-btn-DBA             \[[@B3-molecules-21-00437]\]   113   25.9       798.5151              798.5128       8-ptdn-BHA               \[[@B6-molecules-21-00437]\]
  40    12.0       702.312               702.3845       8-hxn-BA              \[[@B4-molecules-21-00437]\]   114   25.9       824.5307              824.5305       8-pme-DBA \*             
  41    12.0       658.3586              658.3599       8-vlr-BHA \*                                         115   26.0       822.5515              822.5527       8-ole-13-DMDBA \*        
  42    12.2       916.5417              916.5399       8-thode-BA \*                                        116   26.0       796.5358              796.5371       8-pal-DMDBA \*           
  43    12.3       886.5311              886.5662       8-thode-BHA \*                                       117   26.1       822.5515              822.5511       8-ole-3-DMDBA \*         
  44    12.5       728.4004              728.3993       8-hnne-BHA \*                                        118   26.1       828.5256              828.5251       8-pal-BMA                \[[@B20-molecules-21-00437]\]
  45    13.0       900.5468              900.5474       8-thode-DBA \*                                       119   26.1       796.5358              796.5368       8-pal-13-DMDBA \*        
  46    13.2       790.4372              790.4367       8-dhudn-BMA                                          120   26.2       804.5409              804.5387       8-lino-DMDDBA \*         
  47    13.3       672.3742              672.3752       8-vlr-DBA \*                                         121   26.2       884.5519              884.5494       8-ole-10-OH-BA           \[[@B6-molecules-21-00437]\]
  48    13.3       916.5417              916.5401       8-thnde-BMA \*                                       122   26.3       854.5413              854.5403       8-ole-BMA                \[[@B6-molecules-21-00437]\]
  49    13.5       800.4216              800.4234       8-dded-BMA \*                                        123   26.6       850.5464              850.5459       8-lino-DBA               \[[@B8-molecules-21-00437]\]
  50    13.6       774.4423              774.4400       8-dhudn-BHA                                          124   26.8       880.5569              880.5540       8-ecde-BMA               \[[@B12-molecules-21-00437]\]
  51    13.6       782.5202              782.5161       8-pal-DMBHA \*                                       125   26.9       834.5515              834.5494       8-lino-3,13-DDBA         \[[@B18-molecules-21-00437]\]
  52    15.1       716.4004              716.3982       8-otn-BMA \*                                         126   26.9       842.5413              842.5396       8-pal-BA                 \[[@B20-molecules-21-00437]\]
  53    15.2       884.5155              884.5174       8-dhodd-BMA \*                                       127   26.9       812.5307              812.5292       8-ptdn-DBA               \[[@B8-molecules-21-00437]\]
  54    15.9       730.4161              730.4154       8-nnn-BMA \*                                         128   27.0       894.5362              894.5336       3-Acetyl-8-lino-BMA      \[[@B16-molecules-21-00437]\]
  55    16.2       898.5311              898.5307       8-dhodd-BA \*                                        129   27.1       868.5569              868.5576       8-ole-BA                 \[[@B20-molecules-21-00437]\]
  56    16.3       886.5311              886.5318       8-dhode-BMA\*                                        130   27.2       838.5464              838.5443       8-ole-BHA                \[[@B6-molecules-21-00437]\]
  57    16.8       900.5468              900.5438       8-dhode-BA \*                                        131   27.4       806.5565              806.5512       8-ole-DMDDBA \*          
  58    17.0       866.5049              866.5054       8-hodt-BMA \*                                        132   27.5       812.5307              812.5300       8-pal-BHA                \[[@B6-molecules-21-00437]\]
  59    17.1       868.5206              868.5191       8-dhodd-BHA \*                                       133   27.6       856.5569              856.5553       8-str-BMA                \[[@B10-molecules-21-00437]\]
  60    17.3       888.5468              888.5438       8-dhstr-BMA \*                                       134   27.7       836.5619              836.5712       8-ole-3,13-DDBA \*       
  61    17.4       870.5362              870.5335       8-dhode-BHA \*                                       135   28.0       826.5464              826.5465       8-pal-DBA                \[[@B6-molecules-21-00437]\]
  62    18.1       884.5313              884.5292       8-hodd-10-OH-BMA \*                                  136   28.2       926.6352              926.6308       8-tcn-BMA \*             
  63    18.1       884.5519              884.5486       8-dhode-DBA \*                                       137   28.3       780.5409              780.5384       8-pal-DMDDBA \*          
  64    18.4       880.5206              880.5199       8-hodt-BA \*                                         138   28.4       842.5413              842.5399       8-hpdn-BMA               \[[@B6-molecules-21-00437]\]
  65    18.4       850.500               850.5096       8-hodt-BHA \*                                        139   28.5       852.5620              852.5620       8-ole-DBA                \[[@B6-molecules-21-00437]\]
  66    18.5       872.5519              872.5518       8-dhstr-BHA \*                                       140   28.9       912.6195              912.6194       8-dcn-BMA \*             
  67    18.8       868.5206              868.5196       8-hodd-BMA \*                                        141   29.0       810.5515              810.5490       8-pal-3,13-DDBA          \[[@B8-molecules-21-00437]\]
  68    18.8       910.5311              910.5304       8-dhecte-BMA \*                                      142   29.7       870.5726              870.5569       8-str-BA                 \[[@B20-molecules-21-00437]\]
  69    19.4       882.5368              882.5349       8-hodd-BA \*                                         143   29.7       954.6665              954.6648       8-ttcn-BA                \[[@B5-molecules-21-00437]\]
  70    19.8       924.5548              924.5455       8-dhhctte-BA \*                                      144   30.5       840.5620              840.5583       8-hpdn-DBA               \[[@B8-molecules-21-00437]\]
  71    20.1       852.5256              852.5264       8-hodd-BHA \*                                        145   30.5       840.5620              840.5636       8-str-BHA                \[[@B8-molecules-21-00437]\]
  72    20.1       870.5362              870.5359       8-hode-BMA \*                                        146   30.5       940.6508              940.6506       8-ttcn-BMA               \[[@B21-molecules-21-00437]\]
  73    21.0       864.5256              864.5255       8-hodt-DBA \*                                        147   30.9       926.6279              926.6308       8-dcn-BA                 \[[@B8-molecules-21-00437]\]
  74    21.2       866.5413              866.5410       8-hodd-DBA \*                                        148   31.6       896.6246              896.6225       8-dcn-BHA                \[[@B21-molecules-21-00437]\]

Abbreviations: fmr (fumaric acid), bte (butenoic acid), hbte (hydroxybutenoic acid), scn (succinic acid), btn (butanoic acid), hbtn (hydroxybutanoic acid), dhbtn (dihydroxybutanoic acid), gtn (glutaconic acid), ogtr (oxoglutaric acid), gtr (glutaric acid), vlr (valeric acid), hvlr (hydroxyvaleric acid), act (aconitic acid), adp (adipic acid), hadp (hydroxyadipic acid), hxn (hexanoic acid), dohpnd (dioxoheptanedioic acid), otn (octanoic acid), hnne (hydroxynonenoic acid), azl (azelaic acid), nnn (nonanoic acid), sbc (sebacic acid), dhudn (dihydroxyundecanoic acid), dded (dodecenedioic acid), laur (lauric acid), myr (myristic acid), ptde (pentadecenoic acid), ptdn (pentadecanoic acid), pmde (palmitadienoic acid), pme (palmitoleic acid), pal (palmitic acid), hpdde (heptadecadienoic acid), hpde (heptadecenoic acid), hpdn (heptadecanoic acid), linolen (linolenic acid), hodt (hydroxyoctadecatrienoic acid), lino (linoleic acid), hodd (hydroxyoctadecadienoic acid), dhodd (dihydroxyloctadecadienoic acid), ole (oleic acid), hode (hydroxyoctadecenoic acid), dhode (dihydroxyoctadecenoic acid), thode (trihydroxyoctadecenoic acid), str (stearic acid), hstr (hydroxystearic acid), dhstr (dihydroxy stearic acid), thnde (trihydroxynonadecenoic acid), dhecte (dihydroxyeicosatrienoic acid), ecde (eicosadienoic acid), dhhctte (dihydroxyhenicosatetraenoic acid), dcn (docosanoic acid), tcn (tricosanoic acid), ttcn (tetracosanoic acid), gvl (glucovanillic acid), gcf (glucocaffeic acid), gfr (glucoferulic acid). \* New compounds.

molecules-21-00437-t003_Table 3

###### 

Fatty acid side chains in lipo-alkaloids.

  No.   MF                  Possible Structure         No. of LAs   Ref.                                                     No.   MF                  Possible Structure                No. of LAs   Ref.
  ----- ------------------- -------------------------- ------------ -------------------------------------------------------- ----- ------------------- --------------------------------- ------------ ------------------------------
  1     C~3~H~6~O~2~        Propanoic acid             ND           \[[@B1-molecules-21-00437]\]                             40    C~17~H~30~O~2~ \*   Heptadecadienoic acid             2            
  2     C~4~H~4~O~4~        Fumaric acid               2            \[[@B11-molecules-21-00437]\]                            41    C~17~H~32~O~2~      Heptadecenoic acid                1            \[[@B1-molecules-21-00437]\]
  3     C~4~H~6~O~2~ \*     Butenoic acid              1                                                                     42    C~17~H~34~O~2~      Heptadecanoic acid                2            \[[@B1-molecules-21-00437]\]
  4     C~4~H~6~O~3~ \*     Hydroxybutenoic acid       1                                                                     43    C~18~H~30~O~2~      Linolenic acid                    9            \[[@B1-molecules-21-00437]\]
  5     C~4~H~6~O~4~        Succinic acid              2            \[[@B1-molecules-21-00437],[@B2-molecules-21-00437]\]    44    C~18~H~30~O~3~ \*   Hydroxyoctadecatrienoic acid      4            
  6     C~4~H~6~O~5~        Malic acid                 ND                                                                    45    C~18~H~32~O~2~      Linoleic acid                     12           \[[@B1-molecules-21-00437]\]
  7     C~4~H~8~O~2~        Butanoic acid              3            \[[@B11-molecules-21-00437]\]                            46    C~18~H~32~O~3~ \*   Hydroxyoctadecadienoic acid       5            
  8     C~4~H~8~O~3~        Hydroxybutanoic acid       3            \[[@B11-molecules-21-00437]\]                            47    C~18~H~32~O~4~ \*   Dihydroxyoctadecadienoic acid     3            
  9     C~4~H~8~O~4~ \*     Dihydroxybutanoic acid     1                                                                     48    C~18~H~34~O~2~      Oleic acid                        11           \[[@B1-molecules-21-00437]\]
  10    C~5~H~6~O~4~        Glutaconic acid            2            \[[@B11-molecules-21-00437]\]                            49    C~18~H~34~O~3~ \*   Hydroxyoctadecenoic acid          4            
  11    C~5~H~6~O~5~ \*     Oxoglutaric acid           1                                                                     50    C~18~H~34~O~4~ \*   Dihydroxyoctadecenoic acid        4            
  12    C~5~H~8~O~4~        Glutaric acid              1            \[[@B2-molecules-21-00437]\]                             51    C~18~H~34~O~5~ \*   Trihydroxyoctadecenoic acid       4            
  13    C~5~H~10~O~2~       Valeric acid               4                                                                     52    C~18~H~36~O~2~      Stearic acid                      3            \[[@B1-molecules-21-00437]\]
  14    C~5~H~10~O~3~ \*    Hydroxyvaleric acid        1                                                                     53    C~18~H~36~O~3~ \*   Hydroxystearic acid               1            
  15    C~6~H~6~O~6~ \*     Aconitic acid              5                                                                     54    C~18~H~36~O~4~ \*   Dihydroxy stearic acid            2            
  16    C~6~H~10~O~4~       Adipic acid                3            \[[@B2-molecules-21-00437],[@B11-molecules-21-00437]\]   55    C~19~H~32~O~2~      Nonadecatrienoic acid             ND           \[[@B8-molecules-21-00437]\]
  17    C~6~H~10~O~5~ \*    Hydroxyadipic acid         5                                                                     56    C~19~H~34~O~2~      Nonadecadienoic acid              ND           \[[@B1-molecules-21-00437]\]
  18    C~6~H~12~O~2~       Hexanoic acid              1                                                                     57    C~19~H~36~O~2~      Nonadecenoic acid                 ND           \[[@B1-molecules-21-00437]\]
  19    C~7~H~8~O~4~ \*     Heptadienedioic acid       1                                                                     58    C~19~H~36~O~5~ \*   Trihydroxynonadecenoic acid       1            
  20    C~7~H~8~O~6~ \*     Dioxoheptanedioic acid     1                                                                     59    C~19~H~38~O~2~      Nonadecanoic acid                 ND           \[[@B1-molecules-21-00437]\]
  21    C~7~H~12~O~4~       Pimelic acid               ND           \[[@B2-molecules-21-00437]\]                             60    C~20~H~30~O~2~      Eicosapentaenoic acid             ND           \[[@B1-molecules-21-00437]\]
  22    C~8~H~14~O~4~       Suberic acid               ND           \[[@B2-molecules-21-00437]\]                             61    C~20~H~32~O~2~      Eicosatetraenoic acid             ND           \[[@B1-molecules-21-00437]\]
  23    C~8~H~16~O~2~ \*    Octanoic acid              1                                                                     62    C~20~H~34~O~2~      Eicosatrienoic acid               ND           \[[@B1-molecules-21-00437]\]
  24    C~9~H~16~O~3~ \*    Hydroxynonenoic acid       3                                                                     63    C~20~H~34~O~4~ \*   Dihydroxyeicosatrienoic acid      1            
  25    C~9~H~16~O~4~       Azelaic acid               2            \[[@B12-molecules-21-00437]\]                            64    C~20~H~36~O~2~      Eicosadienoic acid                1            \[[@B1-molecules-21-00437]\]
  26    C~9~H~18~O~2~ \*    Nonanoic acid              1                                                                     65    C~20~H~38~O~2~      Eicosenoic acid                   ND           \[[@B1-molecules-21-00437]\]
  27    C~10~H~18~O~4~      Sebacic acid               1            \[[@B2-molecules-21-00437]\]                             66    C~20~H~40~O~2~      Eicosanoic acid                   ND           \[[@B1-molecules-21-00437]\]
  28    C~11~H~20~O~4~      Undecanedioic acid         ND           \[[@B2-molecules-21-00437]\]                             67    C~21~H~32~O~2~      Henicosapentaenoic acid           ND           \[[@B1-molecules-21-00437]\]
  29    C~11~H~22~O~4~ \*   Dihydroxyundecanoic acid   2                                                                     68    C~21~H~34~O~2~      Henicosatetraenoic acid           ND           \[[@B1-molecules-21-00437]\]
  30    C~12~H~20~O~4~ \*   Dodecenedioic acid         1                                                                     69    C~21~H~34~O~4~ \*   Dihydroxyhenicosatetrenoic acid   1            
  31    C~12~H~24~O~2~      Lauric acid                1            \[[@B1-molecules-21-00437]\]                             70    C~22~H~32~O~2~      Docosahexaenoic acid              ND           \[[@B1-molecules-21-00437]\]
  32    C~14~H~24~O~2~      Tetradecadienoic acid      ND           \[[@B1-molecules-21-00437]\]                             71    C~22~H~44~O~2~      Docosanoic acid                   3            \[[@B1-molecules-21-00437]\]
  33    C~14~H~26~O~2~      Tetradecenoic acid         ND           \[[@B1-molecules-21-00437]\]                             72    C~23~H~42~O~2~      Tricosadienoic Acid               ND           \[[@B1-molecules-21-00437]\]
  34    C~14~H~28~O~2~      Myristic acid              1            \[[@B1-molecules-21-00437]\]                             73    C~23~H~44~O~2~      Tricosenoic Acid                  ND           \[[@B1-molecules-21-00437]\]
  35    C~15~H~28~O~2~      Pentadecenoic acid         2            \[[@B1-molecules-21-00437]\]                             74    C~23~H~46~O~2~ \*   Tricosanoic Acid                  1            
  36    C~15~H~30~O~2~      Pentadecanoic acid         4            \[[@B1-molecules-21-00437]\]                             75    C~24~H~46~O~2~      Tetracosenoic acid                ND           \[[@B1-molecules-21-00437]\]
  37    C~16~H~28~O~2~      Palmitadienoic acid        1            \[[@B1-molecules-21-00437]\]                             76    C~24~H~48~O~2~      Tetrecosanoic acid                2            \[[@B1-molecules-21-00437]\]
  38    C~16~H~30~O~2~      Palmitoleic acid           4            \[[@B1-molecules-21-00437]\]                             77    C~25~H~50~O~2~      Pentacosanoic acid                ND           \[[@B1-molecules-21-00437]\]
  39    C~16~H~32~O~2~      Palmitic acid              11           \[[@B1-molecules-21-00437]\]                                                                                                      

\* Indicates the side chains detected for the first time; MF: molecular formula; LAs: lipo-alkaloids; ND: not detected.
